← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$102K

Shares

800

Price

$127

Filed

Sep 9

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Coleman Mark

Title

CIK

0001658379

Roles

Director

Transaction Details

Transaction Date

2025-09-08

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,437

Footnotes

Represents the open market purchase of shares of the Issuer's common stock. | Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.

Filing Info

Accession No.

0000950170-25-113874

Form Type

4

Issuer CIK

0001579428

Coleman Mark's History

Date Ticker Type Value
2026-02-26 AXSM $4.0M
2026-02-23 AXSM M $31K
2026-02-23 AXSM M $0
2026-02-20 AXSM M $62K
2026-02-20 AXSM M $0
2026-02-10 AXSM M $42K
2026-02-10 AXSM M $0
2025-09-08 AXSM $102K
2025-09-08 AXSM $37K
2025-09-08 AXSM $62K

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22